Earnings (Loss) Per Common Share

6 Months Ended

Jun. 30, 2021

The following table sets forth the computation of basic and diluted earnings per share available for common stockholders for the three and six months ended June 30, 2021 and 2020 (in thousands, except per share data):


	For the Three Months Ended June 30,				For the Six Months Ended June 30,
	2021		2020		2021		2020
Income (loss) from continuing operations	$	(9,107)	$	(202,013)	$	(20,297)	$	(280,500)
Income (loss) from discontinued operations, net of tax	—		(1,508)		1,383		(1,773)
Net income (loss)	(9,107)		(203,521)		(18,914)		(282,273)
Less:
Net loss attributable to non-controlling interests	—		—		—		—
Net income (loss) available for common shareholders - basic and diluted	$	(9,107)	$	(203,521)	$	(18,914)	$	(282,273)

Weighted-average common shares outstanding - basic and diluted	85,448		85,349		85,056		84,977

Income (loss) per common share
Basic and diluted
Continuing operations	$	(0.11)	$	(2.37)	$	(0.24)	$	(3.30)
Discontinued operations	—		(0.01)		0.02		(0.02)
Basic and diluted income (loss) per share attributable to common shareholders of Evolent Health, Inc.	$	(0.11)	$	(2.38)	$	(0.22)	$	(3.32)

Anti-dilutive shares (in thousands) excluded from the calculation of weighted-average common shares presented above for the three and six months ended June 30, 2021 and 2020 are presented below:


	For the Three Months Ended June 30,		For the Six Months Ended June 30,
	2021	2020	2021	2020
Restricted stock units ("RSUs"), performance-based RSUs and leveraged stock units ("LSUs")	2,052	554	1,793	376
Stock options	1,801	711	1,833	841
Convertible senior notes	12,696	10,361	12,696	10,361
Total	16,549	11,626	16,322	11,578